Healthcare Focus

Exclusively Healthcare, Built for Growth

Close-up of microscope objective lenses in a lab, with a cool blue tone and shallow depth of field.

Healthcare‑First Investing

1315 Capital is a private equity firm exclusively focused on healthcare growth equity and growth buyout opportunities. We partner with commercial-stage companies across healthcare services, pharma/medtech products, pharma/medtech outsourcing, and health & wellness verticals.

Scientist in mask and gown using a binocular microscope at a lab bench, with a laptop blurred in the background.

Subsectors of Focus

We concentrate on four verticals where we have significant experience and built domain knowledge. We leverage this expertise to effectively source, diligence, and provide value to companies with market leading potential.

Investment Criteria
Close-up of a hospital patient monitor displaying ECG and vital sign waveforms.

Healthcare Services

We invest in services that lower cost and complexity of healthcare while improving outcomes, spanning administrative and clinical functions and along the tech-enabled continuum. Representative areas of interest include:

  • Revenue cycle management and medical coding services
  • Specialized clinical staffing and training programs
  • Remote monitoring and telemedicine solutions
  • Specialty medical distribution and procurement offerings
Close-up of a pharmaceutical rotary filling/press machine, showing a circular tray packed with blue tablets or pellets under metal tooling.

Pharma/Medtech Products

We support commercial-stage medtech and pharma products with proven clinical and economic value that have recurring provider and patient needs. Representative areas of interest include:

  • Medical devices and surgical technologies
  • Sterile injectable pharmaceuticals
  • Diagnostics and life sciences tools
  • Medical simulation and educational products
Industrial robotic arm with a gripper operating on a high-speed manufacturing line.

Pharma/Medtech Outsourcing

We back specialized platforms providing invaluable expertise and services across research, development, manufacturing, and commercial operations to life sciences companies that are increasingly seeking efficiency in their internal operations. Representative areas of interest include:

  • Contract development and manufacturing organizations (CDMOs)
  • Preclinical drug discovery and bioanalytical services
  • Medical coatings and diagnostic reagents
  • Particle processing and microencapsulation technologies
Acupuncture needles resting in a small wooden bowl on a rustic table, with leafy greenery in the background.

Health & Wellness

We selectively invest in health and wellness products and services platforms that are endorsed by healthcare professionals, backed by clinical data, and have attractive unit economics, and offer consumers a cash-pay option. Representative areas of interest include:

  • Nutritional supplements and natural health products
  • Continuous glucose monitoring and nutritionist services
  • Aesthetics devices and cosmeceutical products
  • Diagnostic labs focused on addressing root case of complex disease
Learn More About Our Investment Criteria